Latest Tumor markers Stories
The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels.
-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International
LONDON, April 8, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Globally, over one million men a year have prostate tissue samples taken to check for signs of prostate cancer. This procedure can involve up to 12 large biopsy needles and has been called barbaric...
Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70.
Fulgent Diagnostics announces a clinical BRCA1/BRCA2 full gene sequencing test for $500. Temple City, California (PRWEB) March 26, 2014 In addition to
A study published in last month’s Journal of Clinical Oncology suggests that women with the BRCA1 gene mutation may significantly reduce their chances of ovarian cancer if they have their ovaries
The gene known to be associated with breast cancer susceptibility, BRCA 1, plays a critical role in the normal metabolic function of skeletal muscle.
COMBINING SCIENCE AND ART, THE SCULPTURE ECHOES THE OPTIMISM SURROUNDING RECENT BREAKTHROUGHS IN BREAST CANCER RESEARCH NEW YORK, Feb.
New prostate cancer screening option combines existing tests to substantially increase accuracy CHICAGO, Feb.
- To fire mitraille at.